Merkoša sitáhtat
APA-čujuhus (7. p.)
Digomann, D., Heiduk, M., Reiche, C., Glück, J., Kahlert, C., Mirtschink, P., . . . Seifert, A. M. (2023). Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer. Nature Portfolio.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Digomann, David, et al. Serum Immune Checkpoint Profiling Identifies Soluble CD40 as a Biomarker for Pancreatic Cancer. Nature Portfolio, 2023.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Digomann, David, et al. Serum Immune Checkpoint Profiling Identifies Soluble CD40 as a Biomarker for Pancreatic Cancer. Nature Portfolio, 2023.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.